No abstract available
Publication types
-
Clinical Trial
-
Clinical Trial, Phase I
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Burns, Chemical / complications
-
Corneal Ulcer / etiology
-
Corneal Ulcer / prevention & control*
-
Dipeptides / pharmacology*
-
Dipeptides / therapeutic use
-
Dipeptides / toxicity*
-
Eye Infections / complications
-
Gingiva / enzymology
-
Humans
-
Inflammation
-
Matrix Metalloproteinase 8
-
Matrix Metalloproteinase Inhibitors
-
Metalloendopeptidases / antagonists & inhibitors*
-
Mice
-
Peritonitis / chemically induced
-
Peritonitis / prevention & control
-
Phorbol 12,13-Dibutyrate / pharmacology
-
Pseudomonas Infections / complications
-
Rabbits
-
Reference Values
-
Skin / enzymology
-
Skin Diseases / chemically induced
-
Skin Diseases / pathology
-
Skin Diseases / prevention & control
-
Thioglycolates
Substances
-
Dipeptides
-
Matrix Metalloproteinase Inhibitors
-
N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide
-
Thioglycolates
-
Phorbol 12,13-Dibutyrate
-
Metalloendopeptidases
-
Matrix Metalloproteinase 8